Same-store sales declined 11 percent in the quarter, less than a drop of 16.3 percent projected by analysts.
Comparable online sales in the U.S. skyrocketed more than 173 percent on a year-over-year basis.
On an adjusted basis, profit rose to $2.01, easily beating analysts’ average estimate of $1.08 per share.
On an adjusted basis, profit rose to 76 cents per share, while analysts on average were expecting the company to report a loss of 4 cents per share.
Same-store sales jumped by 5.1 percent on a year-over-year basis, beating the analysts’ average forecast of 4.7 percent growth.
Snap is initially launching Spotlight in 11 countries including the United States and Canada, with a plan to add more in the coming time.
AstraZeneca will sell its vaccine to governments at significantly lower prices as compared to Pfizer and Moderna.
The decision is expected to cost the company a hefty amount of $1.2 billion
The company reported an adjusted profit of 54 cents per share, easily beating the analysts’ average estimate of 5 cents per share.
The company posted a profit of $1 million for the three months ended September 30, as compared to $91 million in the same period last year.
